Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
7708843
Reference Type
Journal Article
Title
Effect of zinc or zinc plus arginine supplementation on antibody titre and lymphocyte subsets after influenza vaccination in elderly subjects: a randomized controlled trial
Author(s)
Provinciali, M; Montenovo, A; Di Stefano, G; Colombo, M; Daghetta, L; Cairati, M; Veroni, C; Cassino, R; Della Torre, F; Fabris, N
Year
1998
Is Peer Reviewed?
Yes
Journal
Age and Ageing
ISSN:
0002-0729
EISSN:
1468-2834
Volume
27
Issue
6
Page Numbers
715-722
Language
English
PMID
10408666
DOI
10.1093/ageing/27.6.715
Web of Science Id
WOS:000077415700022
Abstract
OBJECTIVE:
to evaluate whether oral supplementation with zinc or zinc/arginine increases the antibody response to influenza vaccine or modulates the lymphocyte phenotype in elderly subjects.
DESIGN:
a randomized controlled trial with two supplemented groups and one control group.
SETTING:
a community nursing home.
PARTICIPANTS:
384 subjects aged 64-100 (mean age 82 years) examined in three separate studies.
INTERVENTION:
oral supplementation with zinc (400 mg/day) or zinc plus arginine (4 g/day) for 60 days starting 15 days before influenza vaccination. The control groups received vaccine only.
MEASUREMENTS:
haematological and nutritional indices, antibody titre against influenza viral antigens, lymphocyte phenotype.
RESULTS:
supplementation with zinc or zinc plus arginine increased zinc plasma concentrations restoring the age-related impairment in zinc concentrations to values found in younger people. The antibody titre against influenza viral antigens was not increased in zinc or zinc/arginine supplemented groups in comparison with subjects receiving vaccine alone. The number of CD3, CD4 or CD8 lymphocytes was not affected by zinc or zinc/arginine supplementation.
CONCLUSION:
prolonged supplementation with zinc or zinc/arginine restores zinc plasma concentrations but is ineffective in inducing or ameliorating the antibody response after influenza vaccination in elderly subjects.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity